12 Supplements Known to Interfere with Prescription Medications

11. Fish Oil and Omega-3 Supplements - The Cardiovascular Complication

Fish oil and omega-3 fatty acid supplements, among the most popular dietary supplements worldwide, present significant interaction risks primarily through their antiplatelet effects and influence on cardiovascular medications. These supplements, containing EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), can significantly enhance the effects of anticoagulant and antiplatelet medications, increasing bleeding risk and potentially leading to serious hemorrhagic complications. The interaction is particularly concerning with warfarin, where high-dose omega-3 supplementation can increase INR values and bleeding time, requiring careful monitoring and potential dose adjustments. The mechanism involves omega-3 fatty acids' effects on platelet aggregation, prostaglandin synthesis, and blood viscosity, creating additive effects when combined with pharmaceutical anticoagulants. Fish oil supplements also interact with antihypertensive medications, where the omega-3 fatty acids' modest blood pressure-lowering effects can cause additive hypotension, particularly in patients taking multiple cardiovascular medications. The supplements can affect the absorption and metabolism of fat-soluble vitamins and medications, potentially altering the effectiveness of certain drugs that require fat for absorption. Additionally, fish oil supplements may interact with immunosuppressive medications, as omega-3 fatty acids have anti-inflammatory and immune-modulating effects that could potentially interfere with intended immunosuppression. The interaction risk is dose-dependent, with higher doses (typically above 3 grams daily) posing greater risks, and the effects may persist for several days after discontinuation due to the incorporation of omega-3